...
首页> 外文期刊>Journal of human hypertension >Nitrendipine and amlodipine mimic the acute effects of enalapril on renal haemodynamics and reduce glomerular hyperfiltration in patients with chronic kidney disease.
【24h】

Nitrendipine and amlodipine mimic the acute effects of enalapril on renal haemodynamics and reduce glomerular hyperfiltration in patients with chronic kidney disease.

机译:尼群地平和氨氯地平模仿慢性肾病患者的依那普利对肾血流动力学的急性作用并减少肾小球超滤。

获取原文
获取原文并翻译 | 示例
           

摘要

Antihypertensive drugs may have an important effect on glomerular haemodynamics. In chronic nephropathy patients, we compared the effect on glomerular haemodynamics of two second-generation dihydropyridinic agents, nitrendipine and amlodipine, with a first generation dihydropyridinic agent and an ACE-inhibitor, enalapril. In all, 32 patients (pts), divided into four groups, received the different drugs: ENA (enalapril, eight pts), NIF (nifedipine, eight pts), NIT (nitrendipine, eight pts) AML (amlodipine, eight pts). The study assessed the effect on glomerular haemodynamics of a single administration of the test drug in baseline conditions and in glomerular hyperfiltration experimentally induced by amino-acid infusion. The glomerular filtration rate (GFR, measured by inulin clearance), effective renal plasma flow (ERPF, measured by p-aminohippurate clearance), renal vascular resistances (RVR) and filtration fraction (FF) were assessed. Administration of AML and NIT test dose reduced FF, as did ENA, butnot NIF, in both baseline (AML: P=0.005; NIT: P=0.02; ENA: P=0.007) and glomerular hyperfiltration conditions (AML: P=0.0003; NIT: P=0.03; ENA: P=0.00006). In baseline conditions, only ENA resulted in a significant drop in the GFR (P=0.008), while NIF, NIT and AML induced a significant increase (P=0.003, 0.03, 0.0001, respectively). However, in hyperfiltration conditions, NIT (0.08) and AML (0.00003) caused a decrease in the GFR, as did ENA (0.0003) but not NIF. In all the experimental conditions, a RVR reduction and an ERPF increase were observed. Single dose of NIT and AML were effective in attenuating the effect of amino-acid infusion on glomerular filtration, similar to ENA; this effect of NIT and AML on the glomerular filtration rate is not observed under basal conditions.Journal of Human Hypertension (2003) 17, 487-493. doi:10.1038/sj.jhh.1001579
机译:降压药可能对肾小球血流动力学有重要影响。在慢性肾病患者中,我们比较了两种第二代二氢吡啶类药物硝苯地平和氨氯地平与第一代二氢吡啶类药物和一种ACE抑制剂依那普利对肾小球血流动力学的影响。总共分为三组的32例患者(pts)接受了不同的药物:ENA(依那普利,8 pts),NIF(硝苯地平,8 pts),NIT(nitrendipine,8 pts)AML(氨氯地平,8 pts)。该研究评估了在基线条件下以及通过氨基酸输注实验性诱导的肾小球超滤对单次给药试验药物对肾小球血流动力学的影响。评估肾小球滤过率(GFR,通过菊粉清除率测量),有效肾血浆流量(ERPF,通过对氨基马尿酸清除率测量),肾血管阻力(RVR)和滤过率(FF)。在基线(AML:P = 0.005; NIT:P = 0.02; ENA:P = 0.007)和肾小球高滤过状态(AML:P = 0.0003;基线)(EN:P = 0.005; NIT:P = 0.02; ENA:P = 0.007)的情况下,给予AML和NIT测试剂量可降低FF,与ENA一样,但不会降低NIF。 NIT:P = 0.03; ENA:P = 0.00006)。在基线条件下,仅ENA导致GFR显着下降(P = 0.008),而NIF,NIT和AML导致GFR显着上升(分别为P = 0.003、0.03、0.0001)。然而,在超滤条件下,NIT(0.08)和AML(0.00003)导致GFR下降,ENA(0.0003)也不引起NIF。在所有实验条件下,观察到RVR降低和ERPF升高。与ENA相似,单剂量的NIT和AML可有效减弱氨基酸输注对肾小球滤过的作用。在基础条件下未观察到NIT和AML对肾小球滤过率的这种影响。《人类高血压杂志》(2003)17,487-493。 doi:10.1038 / sj.jhh.1001579

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号